Position in ABBV
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$675,454,100
+$59,601,589 QoQ
Shares Held
2,684,208
-5.2% QoQ
Ownership
0.152%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#66
of 4,145 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PRINCIPAL FINANCIAL GROUP INC holds $4,805,415,142 across 12 Drug Manufacturers - General names. ABBV ranks #3 (14.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,255,719 | $1,506,147,163 | |
| 2 | JNJ |
Johnson & Johnson
|
3,383,935 | $859,417,971 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
2,684,208 | $675,454,100 | |
| 4 | MRK |
Merck & Co., Inc.
|
4,751,479 | $610,565,050 | |
| 5 | NVS |
Novartis AG
|
1,565,796 | $245,391,548 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,793,779 | $226,626,038 | |
| 7 | AMGN |
Amgen Inc
|
614,341 | $222,465,162 | |
| 8 | PFE |
Pfizer Inc
|
6,346,636 | $152,826,994 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $675,454,100 | 2,684,208 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $615,852,511 | 2,831,636 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $655,447,784 | 2,868,606 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $664,308,635 | 2,869,088 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $491,547,375 | 2,648,138 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $547,992,226 | 2,615,465 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $438,173,192 | 2,465,803 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $491,204,444 | 2,487,363 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $379,794,163 | 2,214,285 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $410,485,630 | 2,254,177 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $354,462,570 | 2,287,298 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $337,368,540 | 2,263,307 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $307,318,994 | 2,280,999 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $376,590,831 | 2,362,997 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $379,878,526 | 2,350,588 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $311,475,775 | 2,320,809 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $370,572,456 | 2,419,512 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $402,760,024 | 2,484,486 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $340,074,024 | 2,511,625 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $278,066,206 | 2,577,790 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $298,327,715 | 2,648,506 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $289,813,700 | 2,678,005 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $306,031,436 | 2,856,103 | Shares | Defined | 2021-02-23 | |
| 2020-09-30 | $221,274,324 | 2,526,251 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $266,430,181 | 2,713,691 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $164,210,706 | 2,155,279 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||